Esomeprazole and omeprazole may possibly boost the serum concentrations of benzodiazepines (via CYP2C19 inhibition) bringing about greater adverse effects including drowsiness, although the clinical relevance is reduced in most patients – monitor the patient for adverse effects (e. If affected person simply cannot resume their common oral medi